Efficacy and safety of percutaneous transhepatic biliary radiofrequency ablation in patients with malignant obstructive jaundice

doi:10.12998/wjcc.v12.i17.2983

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 17

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1139)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

HTML

551

Figures (1-1)

122

Tables (1-1)

116

Sum=816

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

232

Sum=268

Jun 16, 2024 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Jun 16, 2024; 12(17): 2983-2988
Published online Jun 16, 2024. doi: 10.12998/wjcc.v12.i17.2983

Efficacy and safety of percutaneous transhepatic biliary radiofrequency ablation in patients with malignant obstructive jaundice

Ying Xing, Zheng-Rong Liu, You-Guo Li, Hong-Yi Zhang

Ying Xing, Zheng-Rong Liu, You-Guo Li, Hong-Yi Zhang, Department of General Surgery, Tiantan Hospital, Beijing 100170, China

Author contributions: Xing Y and Liu ZR wrote the manuscript; Xing Y and Zhang HY performed the research; Liu ZR and Li YG designed the research study; All authors have read and approve the final manuscript.

Institutional review board statement: This study was reviewed and approved by the Ethics Committee of Beijing Tiantan Hospital, Approval No. KYSQ 2020-177-01.

Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrolment.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Data sharing statement: No additional data are available.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Hong-Yi Zhang, MD, Surgeon, Department of General Surgery, Tiantan Hospital, No. 119 Fanyang Street, Beijing 100170, China. zhy13910433778@163.com

Received: December 24, 2023
Revised: April 18, 2024
Accepted: May 6, 2024
Published online: June 16, 2024
Processing time: 163 Days and 1.5 Hours

Core Tip

Core Tip: Studied the efficacy and safety of endobiliary radiofrequency ablation using percutaneous transhepatic cholangiodrainage in 17 patients with malignant obstructive jaundice, all patients successfully completed the operation, total bilirubin and direct bilirubin decreased significantly after operation; perioperative biliary bleeding occurred in 2 patients, which was improved after transfusion of blood and other conservative treatments, pancreatitis appeared in 1 patient after the operation, and was improved by medication; during follow-up, the stent patency rate was 100% 71% and 29% at the 1^st, 3^rd, and 6^th postoperative months respectively, with a median survival of 4 months.